Pfizer Stock Jumps On Mixed, But 'Marginally Encouraging,' 2025 Outlook - Investor's Business Daily
- Pfizer Stock Jumps On Mixed, But 'Marginally Encouraging,' 2025 Outlook Investor's Business Daily
- Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround CNBC
- Pfizer’s In-Line Guidance Offers Relief to Weary Investors Yahoo Finance
- Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal